About Us

Calimmune is accelerating the promise of gene therapy to liberate patients from chronic and currently incurable diseases.

Calimmune was founded in 2006 based on breakthrough gene modification and cell delivery technology developed in the labs of Nobel Laureate David Baltimore, Ph.D. (California Institute of Technology), Irvin Chen, Ph.D. (University of California, Los Angeles) and Inder M. Verma, Ph.D. (Salk Institute for Biological Studies).

Our team has since advanced lead development programs with novel ex vivo gene therapies for hematologic diseases. We are privileged to have some of the world’s most respected gene therapy developers, clinicians, scientific advisors and commercialization experts committed to our mission. We are passionate about what we do, and for those we ultimately seek to serve.

The “Calimmune beacon” symbolizes our passion and fierce commitment to helping patients prevail against currently incurable diseases.

Leadership

Our leaders represent the best in science, business, and technology

Louis Breton

Chief Executive Officer, Director

louis-breton

Geoff Symonds, Ph.D.

Head of Scientific Affairs and Collaborations

geoff-symonds

Jeffrey Bartlett, Ph.D.

Chief Scientific Officer

jeffrey-bartlett

Mark Smith

Chief Financial Officer

mark-smith

Bhavin Raval

Chief Accounting Officer

bhavin-raval

Tana Session

Vice President, Human Resources

tana-session

Margo Lunsford

Vice President, Business Technology

margo-lunsford

Salim Yazji, M.D.

Executive Vice President and Chief Medical Officer

salim-yazji

Board of Directors

R. Scott Greer, Chairman

Managing Director, Numenor Ventures LLC

David Baltimore, Ph.D.

President Emeritus, California Institute of Technology

Harry George

Co-founder, Managing General Partner, Solstice Capital

Louis Breton

Chief Executive Officer, Director

Jon Faiz Kayyem, Ph.D.

Senior Vice President, Research and Development, GenMark Diagnostics Inc.

James Sullivan, Ph.D.

Vice President, Pharmaceuticals Discovery, AbbVie

Scientific Advisors

R. Jude Samulski, Ph.D.

Director, UNC Gene Therapy Center

Past President, American Society of Gene & Cell Therapy

Male

Inder Verma, Ph.D.

Laboratory of Genetics, Salk Institute for Biological Studies

Male

HANS-PETER KIEM, M.D., Ph.D.

Clinical Research, Stem Cell Biology, Fred Hutchinson Cancer Research Center

Male

Kenneth Cornetta, M.D.

Director of Vector Production and Testing, Cook Regentec

Male

GERO HÜTTER, M.D.

Medical Director, Cellex GmbH

Male

Irvin Chen, Ph.D.

Director, UCLA AIDS Institute

Male

Barry Bernstein

Vice President, Infectious Disease Development, AbbVie

Male

David Ma

Director, Blood Stem Cell and Cancer Research Unit, Department of Haemotology & Bone Marrow Transplantation, St. Vincent's Hospital, Sydney, Australia

Male